SENSEX NIFTY

Drugs

Jun 22, 2015 at 10:57 | Source: Moneycontrol.com
"The company had signed settlement agreement with few bond holders for settlement of the then outstanding 36,789 bonds of USD 1,000 each in principal value. Out of that 21,511 bonds have already been settled and cancelled," said the drug maker in its filing.
Jun 20, 2015 at 13:48 | Source: PTI
FMCG firm RB said it will do a thorough investigation and collaborate with authorities after the UP Food and Drug Administration alleged a lesser weight in its Dettol soap.
Jun 19, 2015 at 13:36 | Source: PTI
On April 1, the drug firm had said that it would acquire select portfolio of established brands of UCB in India, Nepal, Sri Lanka and Maldives for Rs 800 crore.
Jun 19, 2015 at 13:10 | Source: Moneycontrol.com
"US Court of Appeals for Federal Circuit has again found Teva's US 808 patent for Copaxone to be invalid as indefinite. The company awaits approval from the US Food and Drug Administration (US FDA) to launch the product," said Natco in its filing to the exchange.
Jun 18, 2015 at 11:00 | Source: CNBC-TV18
The most prominent name in the mass exodus is that of its CFO Rajesh Garg, who quit to pursue his entrepreneurial ambitions. Company CEO Subhanu Saxena is overseeing finance functions in the interim.
Jun 18, 2015 at 10:12 | Source: Moneycontrol.com
"Orchid has received approval from the USFDA for the abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets (320 mg) with 180 days of generic drug exclusivity," said the drug maker in its filing.
Jun 17, 2015 at 21:42 | Source: PTI
A day after the UP Food and Drug Administration said it had found detergent in one of the milk samples of Mother Dairy, the co-operative said the tested was done on "loose milk samples collected at village level" which were yet to be accepted by it.
Jun 17, 2015 at 18:50 | Source: PTI
The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets in the strength of 320 mg, Orchid Chemicals & Pharmaceuticals said in a filing to BSE.
Jun 17, 2015 at 18:14 | Source: Reuters
More than a decade after it made headlines globally for offering to make AIDS drugs for under USD 1 a day, Cipla gets nearly half of its sales from India, unlike most of its domestic rivals for whom the US market makes up the bulk of revenues.
Jun 17, 2015 at 17:56 | Source: PTI
The government, however, rejected proposal of drug firm Strides Arcolab to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals and deferred three proposals from other firms.
Messages on Drugs »

maximindia

Platinum Member

682 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th 2014

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th 2014

Market Statistician

Platinum Member

13354 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th 2014

News across the web »
Jun 30, 2015 at 00:45 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.